Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to generate evidence regarding hypophosphatemia after iron infusion in lung transplant recipients in context of anemia and/or iron deficiency.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06112236
Study type Observational
Source University of Zurich
Contact
Status Active, not recruiting
Phase
Start date February 17, 2023
Completion date March 31, 2027

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04519762 - Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU Phase 4
Enrolling by invitation NCT04502784 - Investigation of Hypophosphataemia Following Intravenous Iron
Completed NCT03529058 - Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU
Terminated NCT01011114 - Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant N/A
Completed NCT05098249 - Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia Phase 4
Not yet recruiting NCT06350955 - IV Iron-induced Hypophosphatemia After RYGB Phase 4
Completed NCT00688077 - FGF-23 Suppressibility by Calcitonin N/A
Recruiting NCT04814641 - Hypophosphatemia and Bronchiolitis
Recruiting NCT01660308 - Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia N/A
Active, not recruiting NCT03976440 - Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study
Recruiting NCT05909722 - Validation of the GIDS and Description of Phosphate Disorders
Completed NCT03581591 - Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets Phase 3
Completed NCT03740802 - Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis
Suspended NCT03771105 - The Impact of Phosphate Metabolism on Healthy Aging Early Phase 1
Completed NCT03489993 - FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
Completed NCT00975000 - Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Phase 3
Withdrawn NCT02837523 - Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)
Not yet recruiting NCT06344546 - Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding Syndrome